Each year the OAS Secretary General publishes a proposed Program-Budget for the coming calendar year. The OAS General Assembly meets in a Special Session to approve the Program-Budget. Find these documents from 1998-2013 here.
Each year in April, the OAS Board of External Auditors publishes a report covering the previous calendar year’s financial results. Reports covering 1996-2016 may be found here.
Approximately six weeks after the end of each semester, the OAS publishes a Semiannual Management and Performance Report, which since 2013 includes reporting on programmatic results. The full texts may be found here.
Here you will find data on the Human Resources of the OAS, including its organizational structure, each organizational unit’s staffing, vacant posts, and performance contracts.
The OAS executes a variety of projects funded by donors. Evaluation reports are commissioned by donors. Reports of these evaluations may be found here.
The Inspector General provides the Secretary General with reports on the audits, investigations, and inspections conducted. These reports are made available to the Permanent Council. More information may be found here.
The OAS has discussed for several years the real estate issue, the funding required for maintenance and repairs, as well as the deferred maintenance of its historic buildings. The General Secretariat has provided a series of options for funding it. The most recent document, reflecting the current status of the Strategy, is CP/CAAP-3211/13 rev. 4.
Here you will find information related to the GS/OAS Procurement Operations, including a list of procurement notices for formal bids, links to the performance contract and travel control measure reports, the applicable procurement rules and regulations, and the training and qualifications of its staff.
The OAS Treasurer certifies the financial statements of all funds managed or administered by the GS/OAS. Here you will find the latest general purpose financial reports for the main OAS funds, as well as OAS Quarterly Financial Reports (QFRs).
Every year the GS/OAS publishes the annual operating plans for all areas of the Organization, used to aid in the formulation of the annual budget and as a way to provide follow-up on institutional mandates.
Here you will find information related to the OAS Strategic Plan 2016-2020, including its design, preparation and approval.
National Drug Control System (NDS) project in Central America
Status
report by Mr. Ziggie Malyniwsky,
Chief of Supply Reduction and Control, Executive Secretariat of CICAD
Maritime Drug Trafficking: the work of the Expert Group
Report by Mr. Ziggie Malyniwsky, Chief of Supply Reduction and Control, Executive Secretariat of CICAD
Participation of civil society in realigning Brazil's national drug policy
Presentation by General Paulo Roberto Uchoa, National Anti-drug Secretary of Brazil
Findings of the national studies on the economic and social cost of drugs to society
Presentation by Dr. Augusto Pérez Gómez, lead researcher for the cost program, associate of the University of Medicine and Dentistry of New Jersey, and Director of the "Nuevos Rumbos Corporation", Colombia
IV Cumbre de las Américas /The Fourth Summit of the Americas
Briefing by Mr. Luis Alberto Rodriguez, Director, Office for the Summit Process, Organization of American States
Neuroscience of Psychoactive Substance Use and Dependence (World Health Organization publication, 2004).
Presentation by Dr. Laura Krech, Acting Regional Advisor on Alcohol and Substance Abuse, Pan American Health Organization
Horizontal cooperation: best practices in demand reduction
Presentation by Mrs. María Teresa Chadwick, Executive Secretary of the National Drug Commission of Chile (CONACE)
Environmental and human health assessment of the glyphosate aerial spraying program for coca and poppy control in Colombia: Conclusions of the assessment
Presentation by Dr. Keith Solomon, University of Guelph, Canada Director of the Scientific Assessment Team for the project
Building Evaluation Capacity in the Area of Demand Reduction
Ms. Colleen Ryan, Manager, CDS Evaluation, Risk Management and Reporting, Office of the Drug Strategy Secretariat and Strategic Policy, Health Canada
Facebook
Twitter
